151 related articles for article (PubMed ID: 28919255)
1. SUMO proteins: Guardians of immune system.
Adorisio S; Fierabracci A; Muscari I; Liberati AM; Ayroldi E; Migliorati G; Thuy TT; Riccardi C; Delfino DV
J Autoimmun; 2017 Nov; 84():21-28. PubMed ID: 28919255
[TBL] [Abstract][Full Text] [Related]
2. The role of protein SUMOylation in rheumatoid arthritis.
Dehnavi S; Sadeghi M; Johnston TP; Barreto G; Shohan M; Sahebkar A
J Autoimmun; 2019 Aug; 102():1-7. PubMed ID: 31078376
[TBL] [Abstract][Full Text] [Related]
3. Rhabdoviruses, Antiviral Defense, and SUMO Pathway.
El Asmi F; Brantis-de-Carvalho CE; Blondel D; Chelbi-Alix MK
Viruses; 2018 Dec; 10(12):. PubMed ID: 30513968
[TBL] [Abstract][Full Text] [Related]
4. Interferon controls SUMO availability via the Lin28 and let-7 axis to impede virus replication.
Sahin U; Ferhi O; Carnec X; Zamborlini A; Peres L; Jollivet F; Vitaliano-Prunier A; de Thé H; Lallemand-Breitenbach V
Nat Commun; 2014 Jun; 5():4187. PubMed ID: 24942926
[TBL] [Abstract][Full Text] [Related]
5. Innate link between NF-kappaB activity and ubiquitin-like modifiers.
Lang V; Rodríguez MS
Biochem Soc Trans; 2008 Oct; 36(Pt 5):853-7. PubMed ID: 18793150
[TBL] [Abstract][Full Text] [Related]
6. Manipulation of ubiquitin/SUMO pathways in human herpesviruses infection.
Gan J; Qiao N; Strahan R; Zhu C; Liu L; Verma SC; Wei F; Cai Q
Rev Med Virol; 2016 Nov; 26(6):435-445. PubMed ID: 27550835
[TBL] [Abstract][Full Text] [Related]
7. The SUMO-targeted ubiquitin ligase, Dgrn, is essential for Drosophila innate immunity.
Koltun B; Shackelford E; Bonnay F; Matt N; Reichhart JM; Orian A
Int J Dev Biol; 2017; 61(3-4-5):319-327. PubMed ID: 28621429
[TBL] [Abstract][Full Text] [Related]
8. PIASy mediates NEMO sumoylation and NF-kappaB activation in response to genotoxic stress.
Mabb AM; Wuerzberger-Davis SM; Miyamoto S
Nat Cell Biol; 2006 Sep; 8(9):986-93. PubMed ID: 16906147
[TBL] [Abstract][Full Text] [Related]
9. SUMO and SUMOylation Pathway at the Forefront of Host Immune Response.
K ST; Joshi G; Arya P; Mahajan V; Chaturvedi A; Mishra RK
Front Cell Dev Biol; 2021; 9():681057. PubMed ID: 34336833
[TBL] [Abstract][Full Text] [Related]
10. SUMO modification in apoptosis.
Li P; Jing H; Wang Y; Yuan L; Xiao H; Zheng Q
J Mol Histol; 2021 Feb; 52(1):1-10. PubMed ID: 33225418
[TBL] [Abstract][Full Text] [Related]
11. MxA Mediates SUMO-Induced Resistance to Vesicular Stomatitis Virus.
Maarifi G; Hannoun Z; Geoffroy MC; El Asmi F; Zarrouk K; Nisole S; Blondel D; Chelbi-Alix MK
J Virol; 2016 Jul; 90(14):6598-6610. PubMed ID: 27170750
[TBL] [Abstract][Full Text] [Related]
12. Protein modification by SUMO.
Johnson ES
Annu Rev Biochem; 2004; 73():355-82. PubMed ID: 15189146
[TBL] [Abstract][Full Text] [Related]
13. Small ubiquitin-related modifiers in chains.
Vertegaal AC
Biochem Soc Trans; 2007 Dec; 35(Pt 6):1422-3. PubMed ID: 18031236
[TBL] [Abstract][Full Text] [Related]
14. The mouse small ubiquitin-like modifier-2 (SUMO-2) inhibits interleukin-12 (IL-12) production in mature dendritic cells by blocking the translocation of the p65 subunit of NFκB into the nucleus.
Kim EM; Lee HH; Kim SH; Son YO; Lee SJ; Han J; Bae J; Kim SJ; Park CG; Park Y; Hwang KW; Chun T
Mol Immunol; 2011 Sep; 48(15-16):2189-97. PubMed ID: 21632113
[TBL] [Abstract][Full Text] [Related]
15. Viral Mimicry to Usurp Ubiquitin and SUMO Host Pathways.
Wimmer P; Schreiner S
Viruses; 2015 Aug; 7(9):4854-72. PubMed ID: 26343706
[TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr virus encoded microRNAs target SUMO-regulated cellular functions.
Callegari S; Gastaldello S; Faridani OR; Masucci MG
FEBS J; 2014 Nov; 281(21):4935-50. PubMed ID: 25205475
[TBL] [Abstract][Full Text] [Related]
17. [The role of SUMO in regulation of NF-kappaB signaling pathway].
Yang CH; Hong YD; Wu HJ
Sheng Li Ke Xue Jin Zhan; 2009 Apr; 40(2):154-7. PubMed ID: 19558146
[No Abstract] [Full Text] [Related]
18. Modulation of NF-κB Signaling as a Therapeutic Target in Autoimmunity.
Herrington FD; Carmody RJ; Goodyear CS
J Biomol Screen; 2016 Mar; 21(3):223-42. PubMed ID: 26597958
[TBL] [Abstract][Full Text] [Related]
19. Small ubiquitin-related modifiers: A novel and independent class of autoantigens in primary biliary cirrhosis.
Janka C; Selmi C; Gershwin ME; Will H; Sternsdorf T
Hepatology; 2005 Mar; 41(3):609-16. PubMed ID: 15726652
[TBL] [Abstract][Full Text] [Related]
20. The implication of SUMO in intrinsic and innate immunity.
Hannoun Z; Maarifi G; Chelbi-Alix MK
Cytokine Growth Factor Rev; 2016 Jun; 29():3-16. PubMed ID: 27157810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]